French biotech lands man­u­fac­tur­ing deal in step to­ward com­mer­cial­iza­tion of rare bone dis­ease drug

As a start­up, it can some­times be tough to think too far ahead in the fu­ture. How­ev­er, with a ma­jor man­u­fac­tur­ing part­ner­ship an­nounced Wednes­day, CTO …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.